MedTrace Logo

A Pilot Study to Investigate the Effect of Water-soluble Tomato Extract on TMAO

NCT04160481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2020-03-26

No results posted yet for this study

Summary

To determine the effect of 4 weeks daily consumption of Fruitflow on changes in plasma levels of fasting Trimethylamine N-oxide concentrations (TMAO)

Conditions

  • Cardiovascular Risk Factor

Interventions

DIETARY_SUPPLEMENT

FruitFlow

300mg tomato extract

DIETARY_SUPPLEMENT

Placebo

Maltodextrin

Sponsors & Collaborators

  • DSM Nutritional Products, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-12
Primary Completion
2020-03-13
Completion
2020-03-13

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04160481 on ClinicalTrials.gov